HomeAI · summaries
Storia in 10 fonti
Japanese firm’s dengue vaccine becomes first to get regulatory approval in India
Japanese drug firm Takeda Biopharmaceuticals has received market authorisation from the Drug Controller General of India (DCGI) for QDENGA, making it the first dengue vaccine approved here. The vaccine is designed to protect against all four dengue virus serotypes and for individuals 4 to 60 years of age, says a company statement.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Takeda Biopharmaceuticals gets DCGI nod for dengue vaccine QDENGA
Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individuals aged four to sixty years old. QDENGA…
- ·
newsbytesapp.com
India's 1st ever dengue vaccine has come from Japan
Japanese drugmaker Takeda's QDENGA has become India's first approved dengue vaccine, offering protection against all four virus serotypes without requiring pre-vaccination testing.
